Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 11 min ago
Peer-reviewedLicence not statedClinical Genitourinary Cancer

Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study

  • Elie Rassy
  • Cécile Dalban
  • Emeline Colomba
  • Lisa Derosa
  • Carolina Alves Costa Silva
  • Sylvie Negrier
  • Christine Chevreau
  • Gwenaelle Gravis
  • Stephane Oudard
  • Brigitte Laguerre
  • Philippe Barthelemy
  • Marine Gross Goupil
8 more authors
  • Lionnel Geoffrois
  • Frederic Rolland
  • Antoine Thiery-Vuillemin
  • Florence Joly
  • Sylvain Ladoire
  • Florence Tantot
  • Bernard Escudier
  • Laurence Albiges
Open at sourceDOICite

Related

  1. Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study
    Maud Velev, Cécile Dalban, Christine Chevreau +24
    European Journal of CancerPeer-reviewedLicence not stated17 citedGeneral biologyHAL
  2. Enhancement of Cisplatin Efficacy by the Histone Demethylase Inhibitor JIB-04 in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines
    Kamila Adamczuk, Grzegorz Adamczuk, Michał Kiełbus +2
    CellsPeer-reviewedCC BY 4.0Cell biologyCrossref
  3. Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Emeline Guiard, Florian Clatot, Caroline Even +5
    European Journal of CancerPeer-reviewedPublisher termsFull text20 citedGeneral biologyOncologyHAL
  4. Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
    Emilien Billon, Cécile Dalban, Stephane Oudard +17
    European Urology OncologyPeer-reviewedLicence not stated6 citedGeneral biologyHAL
  5. Postcardiotomy extracorporeal life support after isolated or valve-concomitant coronary artery bypass grafting: An observational multicenter study
    Silvia Mariani, Sacha Matteucci, Bas van Bussel +36
    Journal of Thoracic and Cardiovascular Surgery openPeer-reviewedCC BYGeneral biologyEpidemiology & public healthHAL

Cite

BibTeXRIS
BibTeX
@article{rassy2026efficacy,
  title = {{Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study}},
  author = {Elie Rassy and Cécile Dalban and Emeline Colomba and Lisa Derosa and Carolina Alves Costa Silva and Sylvie Negrier and Christine Chevreau and Gwenaelle Gravis and Stephane Oudard and Brigitte Laguerre and Philippe Barthelemy and Marine Gross Goupil and Lionnel Geoffrois and Frederic Rolland and Antoine Thiery-Vuillemin and Florence Joly and Sylvain Ladoire and Florence Tantot and Bernard Escudier and Laurence Albiges},
  journal = {Clinical Genitourinary Cancer},
  year = {2026},
  month = sep,
  doi = {10.1016/j.clgc.2022.07.003},
  url = {https://hal.science/hal-05744000v1},
}
RIS
TY  - JOUR
TI  - Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
AU  - Elie Rassy
AU  - Cécile Dalban
AU  - Emeline Colomba
AU  - Lisa Derosa
AU  - Carolina Alves Costa Silva
AU  - Sylvie Negrier
AU  - Christine Chevreau
AU  - Gwenaelle Gravis
AU  - Stephane Oudard
AU  - Brigitte Laguerre
AU  - Philippe Barthelemy
AU  - Marine Gross Goupil
AU  - Lionnel Geoffrois
AU  - Frederic Rolland
AU  - Antoine Thiery-Vuillemin
AU  - Florence Joly
AU  - Sylvain Ladoire
AU  - Florence Tantot
AU  - Bernard Escudier
AU  - Laurence Albiges
PY  - 2026
DA  - 2026/09/09
JO  - Clinical Genitourinary Cancer
DO  - 10.1016/j.clgc.2022.07.003
UR  - https://hal.science/hal-05744000v1
SN  - 1558-7673
ER  -